Kindred Biosciences, Inc. Contracts & Agreements

First Amendment to Agreement and Plan of Merger, dated June 30, 2021, by and among Elanco Animal Health Incorporated, Knight Merger Sub, Inc. and Kindred Biosciences, Inc (Filed With SEC on July 1, 2021)

Agreement and Plan of Merger, dated as of June 15, 2021, by and among Kindred Biosciences, Inc., Elanco Animal Health Incorporated and Knight Merger Sub, Inc (Filed With SEC on June 16, 2021)

Exclusive License and Collaboration Agreement between Kindred Biosciences, Inc. and Elanco US Inc. dated May 5, 2021 (filed with this Quarterly Report on Form 10-Q; portions of... (Filed With SEC on May 11, 2021)

Description of the Securities of Kindred Biosciences, Inc. Registered Pursuant to Section 12 of the Securities (Filed With SEC on March 16, 2021)

Office Lease (Filed With SEC on March 16, 2021)

Second Amendment to Loan and Security Agreement among Kindred Biosciences, Inc., KindredBio Equine, Inc., Centaur Biopharmaceutical Services, Inc., Solar Capital, Ltd., as... (Filed With SEC on March 16, 2021)

Letter Agreement between Kindred Biosciences, Inc. and Elanco US Inc. dated December 11, 2020 (portions of the exhibit have been omitted because they are both (i) not material and... (Filed With SEC on March 16, 2021)

First Amendment to Letter Agreement between Kindred Biosciences, Inc. and Elanco US Inc. dated March 8, 2021 (portions of the exhibit have been omitted because they are both (i)... (Filed With SEC on March 16, 2021)

Severance and Release Agreement dated as of July 31, 2020 between Kindred Biosciences, Inc. and Denise Bevers (Filed With SEC on August 5, 2020)

Kindred Biosciences, Inc. 2018 Equity Incentive Plan, as Amended (Filed With SEC on June 17, 2020)

First Amendment to Rights Agreement, dated as of May 11, 2020, between Kindred Biosciences, Inc. and American Stock Transfer & Trust Company, LLC, as Rights Agent (Filed With SEC on May 12, 2020)

At The Market Offering Agreement, dated as of April 8, 2020, between Kindred Biosciences, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 8, 2020)

Description of the Securities of Kindred Biosciences, Inc. Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)

Asset Purchase Agreement dated as of March 16, 2020 between Kindred Biosciences, Inc. and Dechra Limited. (Schedules and exhibits to the Asset Purchase Agreement have been omitted... (Filed With SEC on March 16, 2020)

First Amendment to Loan and Security Agreement dated as of March 16, 2020 among Kindred Biosciences, Inc., KindredBio Equine, Inc., Centaur Biopharmaceutical Services, Inc., Solar... (Filed With SEC on March 16, 2020)

Loan and Security Agreement, dated as of September 30, 2019, by and among Kindred Biosciences, Inc., Solar Capital Ltd., as collateral agent and lender, and the other lenders... (Filed With SEC on October 2, 2019)

Underwriting Agreement, dated as of January 18, 2019, between Kindred Biosciences, Inc. and Barclays Capital Inc. and Stifel, Nicoalus & Company, Incorporated, as representatives... (Filed With SEC on January 18, 2019)

Amendment No. 1 to Amended and Restated Executive Employment Agreement, dated as of October 19, 2018, between Kindred Biosciences, Inc. and Denise Bevers (Filed With SEC on November 7, 2018)

Kindred Biosciences, Inc. 2016 Equity Plan Equity Awards Amendment Agreement Form (Filed With SEC on August 9, 2018)

Kindred Biosciences, Inc. 2016 Equity Plan Option Agreement Amendment Form (Filed With SEC on August 9, 2018)

Strategic Supply Agreement between Kindred Biosciences, Inc. and Pall Corporation dated June 26, 2018 (Filed With SEC on August 9, 2018)

Underwriting Agreement, dated as of June 20, 2018, between Kindred Biosciences, Inc. and Cantor Fitzgerald & Co., as representative of the underwriters (Filed With SEC on June 21, 2018)

Amended and Restated Executive Employment Agreement by and between Kindred Biosciences, Inc. and Richard Chin dated May 22, 2018 (Filed With SEC on May 29, 2018)

Amended and Restated Executive Employment Agreement by and between Kindred Biosciences, Inc. and Denise Bevers dated May 22, 2018 (Filed With SEC on May 29, 2018)

Amended and Restated Executive Employment Agreement by and between Kindred Biosciences, Inc. and Wendy Wee dated May 22, 2018 (Filed With SEC on May 29, 2018)

Amended and Restated Executive Employment Agreement by and between Kindred Biosciences, Inc. and Hangjun Zhan dated May 22, 2018 (Filed With SEC on May 29, 2018)

At Market Issuance Sales Agreement, dated as of May 7, 2018, between Kindred Biosciences, Inc. and and each of B. Riley FBR, Inc. and Oppenheimer & Co. Inc (Filed With SEC on May 7, 2018)

Form of Restricted Stock Unit Award Agreement under 2016 Equity Incentive Plan (Filed With SEC on March 1, 2018)

Office Lease Addendum by and between Kindred Biosciences, Inc. and Oritz Coporation dated April 6, 2017 (Filed With SEC on March 1, 2018)

Office Lease Second Addendum by and between Kindred Biosciences, Inc. and Oritz Coporation dated June 27, 2017 (Filed With SEC on March 1, 2018)

Commercial Manufacture and Supply Agreement between Kindred Biosciences, Inc. and DPT Laboratories, Ltd. dated November 6, 2017 (Filed With SEC on November 7, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on July 28, 2017)

KINDRED BIOSCIENCES, INC. 3,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 12, 2017)

ZIMETA" (DIPYRONE INJECTION) COMMERCIAL MANUFACTURE AND SUPPLY AGREEMENT June 21, 2017 (Filed With SEC on June 26, 2017)

PURCHASE AGREEMENT (Filed With SEC on June 26, 2017)

KINDRED BIOSCIENCES, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as Rights Agent RIGHTS AGREEMENT dated as of May 19, 2017 (Filed With SEC on May 24, 2017)

AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 24, 2017)

KINDRED BIOSCIENCES, INC. 2016 EQUITY INCENTIVE PLAN RESTRICTED STOCK GRANT NOTICE (Filed With SEC on March 1, 2017)

KINDRED BIOSCIENCES, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 19, 2016)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on June 5, 2015)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on June 5, 2015)

KINDRED BIOSCIENCES, INC. 2012 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 13, 2015)

THE ORITZ BUILDING OFFICE LEASE (Filed With SEC on August 13, 2014)

KINDRED BIOSCIENCES 2012 EQUITY INCENTIVE PLAN RESTRICTED STOCK AGREEMENT (Filed With SEC on May 14, 2014)

Common Stock KINDRED BIOSCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 3, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2014)

Common Stock KINDRED BIOSCIENCES, INC. FORM OF UNDERWRITING AGREEMENT (Filed With SEC on March 18, 2014)

KINDRED BIOSCIENCES, INC. 2012 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 18, 2014)

Common Stock KINDREDBIOSCIENCES, INC. UNDERWRITING AGREEMENT , 2013 (Filed With SEC on December 2, 2013)

(State) (Filed With SEC on December 2, 2013)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 13, 2013)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 13, 2013)

INDEMNIFICATION AGREEMENT (Filed With SEC on November 13, 2013)

KINDRED BIOSCIENCES INVESTORS RIGHTS AGREEMENT (Filed With SEC on November 13, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on November 8, 2013)

MEDRIO, INC. MASTER SERVICES AGREEMENT (Filed With SEC on November 8, 2013)

NON-GLP LABORATORY SERVICES AGREEMENT (Filed With SEC on November 8, 2013)

Confidential Proposal Formulation and Development, Commercial manufacturing of a chewable Veterinary tablet 200mg Diacerin (Filed With SEC on November 8, 2013)

Confidential Proposal Formulation and Development, Commercial manufacturing of a chewable Veterinary tablet Prepared For Richard Chin Kindred Biotechnology CEO Proposal #12261200... (Filed With SEC on November 8, 2013)

KINDRED BIOSCIENCES, INC. 2012 EQUITY INCENTIVE PLAN AMENDED AUGUST 2013 (Filed With SEC on November 8, 2013)

KINDRED BIOSCIENCES, INC. 2012 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on November 8, 2013)